Peptide-based immunotherapy: new developments.
Larché
Mark
M
Imperial College, School of Medicine, Dovehouse Street, UK-London SW3 6LY.
D000485:Allergens / Q000737:chemistry*; D000818:Animals; D001514:Bee Venoms / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy*; D007167:Immunotherapy; D008285:Major Histocompatibility Complex / Q000276:immunology; D010446:Peptide Fragments / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D014612:Vaccines / Q000627:therapeutic use
D000485:Allergens; D001514:Bee Venoms; D010446:Peptide Fragments; D014612:Vaccines